Gossamer Bio Inc. Common Stock (GOSS)
Stock · NASDAQ · Health Care
$0.17as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$0.141075
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $84.86M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Gossamer Bio Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 17, 2026 · via SEC EDGAR / Finnhub
Gossamer Bio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- GOSSGossamer Bio Inc. Common Stock$0.17▲ 0.00%Market cap $84.86MP/E —
- ACETAdicet Bio Inc. Common Stock$9.05▲ 0.44%Market cap $86.38MP/E —$6.01$17.44
- LFVNLifevantage Corporation Common Stock (Delaware)$6.6▲ 2.33%Market cap $83.01MP/E 14.23$3.9$14.28
- NMADNomad Power Solutions Inc. Common Stock$4.33▼ 2.04%Market cap $81.57MP/E —$3.12$7.7
- ATHEAlterity Therapeutics Limited American Depositary Shares$4.51▼ 1.10%Market cap $80.78MP/E —$0.01$0.785
- TELOTelomir Pharmaceuticals Inc. Common Stock$1.14▼ 4.20%Market cap $80.47MP/E —$0.8884$2.09
- MAIAMAIA Biotechnology Inc. Common Stock$1.33▼ 3.99%Market cap $80.26MP/E —$0.87$3.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| GOSS Gossamer Bio Inc. Common Stock | $84.86M | — | $0.17 | ▲ 0.00% | |
| ACET Adicet Bio Inc. Common Stock | $86.38M | — | $9.05 | ▲ 0.44% | $6.01$17.44 |
| LFVN Lifevantage Corporation Common Stock (Delaware) | $83.01M | 14.23 | $6.6 | ▲ 2.33% | $3.9$14.28 |
| NMAD Nomad Power Solutions Inc. Common Stock | $81.57M | — | $4.33 | ▼ 2.04% | $3.12$7.7 |
| ATHE Alterity Therapeutics Limited American Depositary Shares | $80.78M | — | $4.51 | ▼ 1.10% | $0.01$0.785 |
| TELO Telomir Pharmaceuticals Inc. Common Stock | $80.47M | — | $1.14 | ▼ 4.20% | $0.8884$2.09 |
| MAIA MAIA Biotechnology Inc. Common Stock | $80.26M | — | $1.33 | ▼ 3.99% | $0.87$3.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Friday's session: most active stocksChartMill · 8/21/2026
- Which stocks are moving before the opening bell on Friday?ChartMill · 8/21/2026
- Gossamer Bio Slides as $250M Financing Hinges on FDA MilestonesBenzinga · 8/21/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/21/2026
- Gossamer Bio Enters Into Securities Purchase Agreement For Up to $250M Structured Private PlacementBenzinga · 8/21/2026
- Curious about the stocks that are showing activity after the closing bell on Friday?ChartMill · 8/14/2026
- Piper Sandler Maintains Overweight on Gossamer Bio, Lowers Price Target to $4Benzinga · 8/14/2026
- Gossamer Bio Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $9.238M Beat $5.193M EstimateBenzinga · 8/13/2026
Insider Activity
Insider Actions →Acquired
1.95M
Disposed
1.13M
- Nathan Steven D · June 4, 2026 · Grant115.0K
- Drynan Skye · June 4, 2026 · Grant115.0K
- Milligan Sandra · June 4, 2026 · Grant115.0K
- Quisel John D · June 4, 2026 · Grant115.0K
- Daniel Thomas O · June 4, 2026 · Grant115.0K
- Cox Russell J. · June 4, 2026 · Grant115.0K
- Smith Robert Paul JR · March 19, 2026 · Grant572.0K
- Smith Robert Paul JR · March 19, 2026 · Grant562.5K
- Smith Robert Paul JR · March 19, 2026 · Disposition572.0K
- Smith Robert Paul JR · March 19, 2026 · Disposition562.5K
- Aranda Richard · March 19, 2026 · Grant30.0K
- Aranda Richard · March 19, 2026 · Grant9.2K
- Aranda Richard · March 19, 2026 · Grant22.8K
- Aranda Richard · March 19, 2026 · Grant40.0K
- Aranda Richard · March 19, 2026 · Grant20.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 166.63M
- Total value held
- $52.29M
- Institutional holders
- 186
Top holders this quarter
- Unknown16.83M
- Unknown10.13M
- Unknown9.39M
- Unknown8.06M
- Unknown7.75M
- Unknown7.47M
- Unknown7.22M
- Unknown5.92M
- Unknown5.28M
- Unknown5.21M
See the full, filterable feed with live charts on the MarketWall dashboard.